Esposito E - Search Results

1

Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study.

Delli Pizzi S, Rossi C, Di Matteo V, Esposito E, Guarnieri S, Mariggiò MA, Franciotti R, Caulo M, Thomas A, Onofrj M, Tartaro A, Bonanni L. Delli Pizzi S, et al. Among authors: esposito e. PLoS One. 2013;8(2):e56501. doi: 10.1371/journal.pone.0056501. Epub 2013 Feb 19. PLoS One. 2013. PMID: 23431380 Free PMC article.

2

Death in the substantia nigra: a motor tragedy.

Esposito E, Di Matteo V, Di Giovanni G. Esposito E, et al. Expert Rev Neurother. 2007 Jun;7(6):677-97. doi: 10.1586/14737175.7.6.677. Expert Rev Neurother. 2007. PMID: 17563251 Review.

3

Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.

Di Matteo V, Pierucci M, Esposito E. Di Matteo V, et al. Among authors: esposito e. J Neurochem. 2004 Apr;89(2):418-29. doi: 10.1111/j.1471-4159.2004.02337.x. J Neurochem. 2004. PMID: 15056285 Free article.

4

Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Di Matteo V, Esposito E. Di Matteo V, et al. Among authors: esposito e. Curr Drug Targets CNS Neurol Disord. 2003 Apr;2(2):95-107. doi: 10.2174/1568007033482959. Curr Drug Targets CNS Neurol Disord. 2003. PMID: 12769802 Review.

5

Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration.

Pierucci M, Di Matteo V, Esposito E. Pierucci M, et al. Among authors: esposito e. J Pharmacol Exp Ther. 2004 Apr;309(1):109-18. doi: 10.1124/jpet.103.062208. Epub 2004 Jan 13. J Pharmacol Exp Ther. 2004. PMID: 14722316

6

Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.

Di Matteo V, Di Giovanni G, Pierucci M, Esposito E. Di Matteo V, et al. Among authors: esposito e. Prog Brain Res. 2008;172:7-44. doi: 10.1016/S0079-6123(08)00902-3. Prog Brain Res. 2008. PMID: 18772026 Review.

7

Involvement of nitric oxide in nigrostriatal dopaminergic system degeneration: a neurochemical study.

Di Matteo V, Pierucci M, Benigno A, Crescimanno G, Esposito E, Di Giovanni G. Di Matteo V, et al. Among authors: esposito e. Ann N Y Acad Sci. 2009 Feb;1155:309-15. doi: 10.1111/j.1749-6632.2008.03678.x. Ann N Y Acad Sci. 2009. PMID: 19250222

8

The unilateral nigral lesion induces dramatic bilateral modification on rat brain monoamine neurochemistry.

Pierucci M, Di Matteo V, Benigno A, Crescimanno G, Esposito E, Di Giovanni G. Pierucci M, et al. Among authors: esposito e. Ann N Y Acad Sci. 2009 Feb;1155:316-23. doi: 10.1111/j.1749-6632.2008.03679.x. Ann N Y Acad Sci. 2009. PMID: 19250223 Free article.

9

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.

Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E. Di Matteo V, et al. Among authors: esposito e. Neuropharmacology. 1999 Aug;38(8):1195-205. doi: 10.1016/s0028-3908(99)00047-7. Neuropharmacology. 1999. PMID: 10462132

10

Serotonin-dopamine interaction: an overview.

Esposito E, Di Matteo V, Di Giovanni G. Esposito E, et al. Prog Brain Res. 2008;172:3-6. doi: 10.1016/S0079-6123(08)00901-1. Prog Brain Res. 2008. PMID: 18772025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,073 results

Search Page

Filters